Switch to:
More From Other Websites
Johnson & Johnson Headed Higher & Higher Jul 01 2016
Owens-Illinois, Korn Ferry, AbbVie and Johnson & Johnson highlighted as Zacks Bull and Bear of the... Jul 01 2016
New Janssen Phase 3 Data In Patients With Moderately To Severely Active Rheumatoid Arthritis Shows... Jun 30 2016
What Is Xencor’s XmAb Technology? Jun 30 2016
Is Pfizer’s Valuation Low Compared to Peers? Jun 30 2016
This 5-Stock Portfolio Makes the Perfect Summer Gift Jun 30 2016
AbbVie, J&J's Imbruvica Gets Breakthrough Therapy Status Jun 30 2016
Q3: BEST CHANCE FOR RETURNS THIS YEAR? Jun 30 2016
The Market Value Fluctuations of the 10 Largest Companies Jun 29 2016
How J&J Defied Brexit and Became the Year's Top Health Care Stock Jun 29 2016
Johnson & Johnson Innovation and Janssen Research & Development Launch World Without Disease... Jun 29 2016
[$$] Tesaro's Cancer Drug Meets Primary Endpoint in Late-Stage Trial Jun 29 2016
Zacks Market Edge Highlights: Johnson & Johnson, Priceline, Target, Tesla and Alphabet Jun 29 2016
Research Report Initiated on Select Major Drug Manufacturers Equities Jun 29 2016
7:44 am Johnson & Johnson confirms ibrutinib (:IMBRUVICA) has been granted a fourth Breakthrough... Jun 29 2016
How to Trade Earnings Season Jun 28 2016
Cramer: The 3 Stocks That Will Tell You If the Rally Is Real Jun 28 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK